Jeffrey Stein, Director at Paratek Pharmaceuticals, Inc. (PRTK), sold 7,000 shares at $1.90 ($13K) on 2023-02-21, disclosed to the SEC on 2023-02-23.
Scheduled sale ($13k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CDTX | BUY | 2024-06-11 | $106K | — | Filing → |
| CDTX | BUY | 2023-08-08 | $48K | — | Filing → |
| CDTX | BUY | 2023-03-27 | $52K | — | Filing → |